COMPOSITION CONTAINING AMORPHOUS SOLIFENACIN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION

摘要

To provide a composition containing amorphous solifenacin or a pharmaceutically acceptable salt thereof, which inhibits the crystallization of amorphous solifenacin or a pharmaceutically acceptable salt thereof during its production and storage and has excellent stability and flowability, and a composition production method that makes it possible to conveniently produce the composition, a pharmaceutical composition containing the composition, an agent and method of inhibiting the crystallization of amorphous solifenacin or a pharmaceutically acceptable salt thereof, an agent and method of stabilizing amorphous solifenacin or a pharmaceutically acceptable salt thereof, and an agent and method of improving the flowability of a composition containing amorphous solifenacin or a pharmaceutically acceptable salt thereof.SOLUTION: The present invention provides a composition contains amorphous solifenacin or a pharmaceutically acceptable salt thereof, synthetic hydrotalcite, and at least one of sugar alcohol and acidic substance.SELECTED DRAWING: None